Clinical Trial Update: Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports completion of a study evaluating prednisolone with vitamins B1, B6, and B12 in patients with post-COVID-19 syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Prednisolone (Prednisolone)
• Vitamin B1 (thiamine)
• Vitamin B12 (cobalamin)
• Vitamin B6 (pyridoxine)

Snippet

Sponsor: Wuerzburg University Hospital | Conditions: Post-COVID-19 Syndrome | Phase 3 | Status: COMPLETED